HIV trials in Africa: Difference between revisions
m adjust REFs |
WikiModEn2 (talk | contribs) Add text and citation. |
||
| (4 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
In 2005 and 2007, randomized controlled trials (RCTs) were carried out in Africa in an attempt to prove a hypothesis of certain [[circumcision advocate|circumcision promoters]] despite the known [[Immunological and protective function of the foreskin| immunological functions]] of the [[foreskin]], to link HIV infection to lack of [[circumcision]]. | In 2005 and 2007, randomized controlled trials (RCTs) were carried out in Africa in an attempt to prove a hypothesis of certain [[circumcision advocate|circumcision promoters]] despite the known [[Immunological and protective function of the foreskin| immunological functions]] of the [[foreskin]], to link [[HIV]] infection to lack of [[circumcision]]. | ||
These trials were carried out in | These trials were carried out in | ||
* South Africa: | * [[South Africa]]: | ||
: {{RCT Auvert et al 2005}} | : {{RCT Auvert et al 2005}} | ||
* Kenya: | * Kenya: | ||
| Line 10: | Line 10: | ||
The 2007 RCTs in Kenya and Uganda were funded by NIAID director [[Anthony Fauci]]. | The 2007 RCTs in Kenya and Uganda were funded by NIAID director [[Anthony Fauci]]. | ||
[[PEPFAR]] (2025) has scrapped its ineffective and harmful "voluntary male medical circumcision" (VMMC) program after 15 years and at least 27,000,000 harmful and useless [[foreskin]] amputations.<ref name="gwarisa2025">{{REFnews | |||
|title=New PEPFAR Waiver Scraps Voluntary Medical Male Circumcision Program | |||
|url=https://healthtimes.co.zw/2025/02/07/new-pepfar-waiver-scraps-voluntary-medical-male-circumcision-program/ | |||
|last=Gwarisa | |||
|first=Michael | |||
|init= | |||
|author-link= | |||
|publisher=Healthtimes | |||
|website= | |||
|date=2025-02-07 | |||
|accessdate=2025-02-16 | |||
|format= | |||
|quote= | |||
}}</ref> The [[United States]] government will no longer pay for harmful circumcisions in Africa. | |||
== 60% HIV protection myth == | == 60% HIV protection myth == | ||
| Line 103: | Line 118: | ||
|DOI=10.1097/JU.0000000000002234 | |DOI=10.1097/JU.0000000000002234 | ||
|accessdate=2022-01-07 | |accessdate=2022-01-07 | ||
}}</ref> <ref name="frisch2021">{{ | }}</ref><ref name="frisch2021">{{FrischM SimonsenJ 2021}}</ref> | ||
{{SEEALSO}} | |||
* [[HIV]] | |||
* [[South Africa]] | |||
}}</ref> | |||
{{REF}} | {{REF}} | ||
| Line 139: | Line 131: | ||
[[Category:South Africa]] | [[Category:South Africa]] | ||
[[Category:Uganda]] | [[Category:Uganda]] | ||
[[de:HIV-Studien in Afrika]] | |||